Literature DB >> 14731384

Chronic daily headache and the revised international headache society classification.

Morris Levin1.   

Abstract

Chronic daily headache (CDH) is surprisingly common. It is best defined as a primary headache disorder with head pain on most days. There are a number of possible secondary causes of persistent headache, including traumatic, vascular, neoplastic, and infectious processes, all of which must be ruled out when the patient with frequent headache is evaluated. However, most patients with CDH seem to have a primary neurophysiologic disorder. This category of primary CDH does not seem to be a homogeneous disorder, but rather one with important subtypes. Several authors have proposed subdivisions of primary CDH such as chronic migraine, evolved migraine, transformed migraine, chronic tension-type headache, new daily persistent headache, and hemicrania continua. The International Headache Society (IHS) Classification published in 1988 did not address CDH other than to define a category "chronic tension-type headache." The revised IHS Classification (ICHD II) attempts to characterize CDH more thoroughly with the addition of chronic migraine and new daily persistent headache diagnoses, but this complex issue continues to defy easy categorization. This article provides a review of thinking about the nature of primary CDH and how ICHD II attempts to organize this category for much needed research purposes.

Entities:  

Mesh:

Year:  2004        PMID: 14731384     DOI: 10.1007/s11916-004-0041-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  21 in total

1.  Etiology and treatment of new daily persistent headache.

Authors:  R W Evans; T D Rozen
Journal:  Headache       Date:  2001-09       Impact factor: 5.887

2.  Chronic post-traumatic headaches classified and compared with natural headaches.

Authors:  D C Haas
Journal:  Cephalalgia       Date:  1996-11       Impact factor: 6.292

Review 3.  Analgesic rebound headache.

Authors:  A M Rapoport
Journal:  Headache       Date:  1988-11       Impact factor: 5.887

4.  Analgesic-induced chronic headache: long-term results of withdrawal therapy.

Authors:  H C Diener; J Dichgans; E Scholz; S Geiselhart; W D Gerber; A Bille
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

5.  Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors.

Authors:  S R Lu; J L Fuh; W T Chen; K D Juang; S J Wang
Journal:  Cephalalgia       Date:  2001-12       Impact factor: 6.292

Review 6.  Central sensitization in tension-type headache--possible pathophysiological mechanisms.

Authors:  L Bendtsen
Journal:  Cephalalgia       Date:  2000-06       Impact factor: 6.292

7.  Chronic daily headache. A clinical and psychological profile before and after treatment.

Authors:  F Mongini; N Defilippi; C Negro
Journal:  Headache       Date:  1997-02       Impact factor: 5.887

8.  "Hemicrania continua": another headache absolutely responsive to indomethacin.

Authors:  O Sjaastad; E L Spierings
Journal:  Cephalalgia       Date:  1984-03       Impact factor: 6.292

9.  Post-traumatic migraine: chronic migraine precipitated by minor head or neck trauma.

Authors:  H D Weiss; B J Stern; J Goldberg
Journal:  Headache       Date:  1991-07       Impact factor: 5.887

Review 10.  Epidemiology and pathogenesis of posttraumatic headache.

Authors:  R C Packard
Journal:  J Head Trauma Rehabil       Date:  1999-02       Impact factor: 2.710

View more
  4 in total

Review 1.  Chronic daily headache in the absence of medication overuse: is daily or continuous pain more treatment-resistant than chronic daily headache with pain-free days?

Authors:  Alvin E Lake
Journal:  Curr Pain Headache Rep       Date:  2005-02

Review 2.  Assessment and management of disability in chronic daily headache.

Authors:  William Pryse-Phillips
Journal:  Curr Pain Headache Rep       Date:  2005-02

3.  Posttraumatic Headache.

Authors:  Marc E Lenaerts; James R Couch; James R Couch
Journal:  Curr Treat Options Neurol       Date:  2004-11       Impact factor: 3.598

4.  Botulinum toxin type a for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial.

Authors:  Luciano Hollanda; Larissa Monteiro; Ailton Melo
Journal:  Neurol Int       Date:  2014-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.